Filter
3941
Filtered Results: 3941
Text search:
drug
distribution
Featured
Recommendations
320
New Publications
1161
Language
Document type
No document type
2502
Studies & Reports
603
Guidelines
454
Manuals
147
Strategic & Response Plan
120
Fact sheets
41
Training Material
39
Situation Updates
22
Infographics
8
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
212
Kenya
127
Global
119
Uganda
106
Ethiopia
101
Nigeria
96
South Africa
82
Sierra Leone
76
Liberia
76
Nepal
73
Western and Central Europe
73
Malawi
71
Tanzania
67
Zambia
61
Myanmar / Burma
60
Ghana
58
Latin America and the Carribbean
58
Bangladesh
55
Rwanda
54
Africa
50
Ukraine
43
Namibia
42
Eastern Europe
37
Zimbabwe
36
Philippines
35
Cambodia
31
Lesotho
30
South–East Asia Region
27
Asia
26
Senegal
25
Botswana
23
Congo, Democratic Republic of
20
Indonesia
20
Russia
20
Burkina Faso
19
Mozambique
19
Colombia
16
East and Southern Africa
16
Syria
15
Haiti
14
Eswatini/ Swaziland
13
Venezuela
12
USA
11
South Sudan
11
West and Central Africa
11
Paraguay
11
Albania
11
Cameroon
10
Thailand
10
Middle East and North Africa
10
Benin
9
Brazil
9
Guinea
8
Pakistan
8
Germany
8
Peru
8
Eastern Europe and Central Asia
8
Tajikistan
8
Sudan
7
Argentina
7
Georgia
7
Moldova
6
Vietnam
6
Iraq
5
Afghanistan
5
North Macedonia
5
Bolivia
5
Laos
5
China
4
El Salvador
4
Sri Lanka
4
Chile
4
Armenia
4
Spain
4
Morocco
3
Jordan
3
Lebanon
3
Turkey
3
Papua New Guinea
3
Western Pacific Region
3
Bhutan
3
Timor Leste/ East Timor
3
Central African Republic
2
Honduras
2
Libya
2
Madagascar
2
Mexico
2
Yemen
2
Fiji
2
Mongolia
2
Southern Africa
2
Iran
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
Gabon
2
Uruguay
2
Tunisia
2
United Kingdom
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Egypt
1
Chad
1
Ireland
1
Serbia
1
Hungary
1
Ecuador
1
Greece
1
Angola
1
Guatemala
1
Nicaragua
1
Palestine
1
North Korea
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1656
Clinical Guidelines
341
Public Health
205
Women & Child Health
141
Key Resources
77
Pharmacy & Technologies
57
Capacity Building
48
Annual Report MEDBOX
1
Toolboxes
HIV
433
Mental Health
345
TB
317
AMR
189
NTDs
157
COVID-19
156
Pharmacy
146
Rapid Response
69
Caregiver
62
Planetary Health
60
NCDs
58
Ebola
49
Refugee
48
Disability
45
Conflict
44
Global Health Education
41
Health Financing Toolbox
26
Natural Hazards
20
Polio
15
Specific Hazards
15
Cholera
14
Zika
14
Social Ethics
7
Health Financing
1
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in distric...
Essential Drug list on page 36!!
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is att...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to S...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com...
International Journal of Drug Policy 24 (2013) e91-98
This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis (TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding year...
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequ...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru... development process towards important regimen characteristics corresponding to the needs of end-users.
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB thro...
Social network-based HIV testing is an approach for engaging sexual and drug injecting partners and social contacts of key population members with HIV and of those who are HIV-negative and at ongoing risk in voluntary HTS.
By addressing people’...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
The publication conveys the quantitative surveillance results focusing on tobacco use and noncommunicable disease (NCD) related behaviours among youth (13–15 years) in Member States of the WHO South-East Asia Region, namely, the Global School-based Student Health Survey (GSHS) and the Global Youth...
To examine how health aid is spent and channelled, including the distribution of resources across countries and between
subsectors. Our aim was to complement the many qualitative critiques of health aid with a quantitative review and to provide ins...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International ... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
This guide can inform any partner that manages or supports public health supply chains. Ministries of health, technical assistance partners, or non-governmental organization (NGO) operating distribution systems can all benefit from conducting a cost...
